Medicina
Department
Hospital Carlos III
Madrid, EspañaPublications in collaboration with researchers from Hospital Carlos III (39)
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
2020
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
-
Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network
Travel Medicine and Infectious Disease, Vol. 37
-
Latent and active tuberculosis infections in migrants and travellers: A retrospective analysis from the Spanish +REDIVI collaborative network
Travel Medicine and Infectious Disease, Vol. 36
2019
-
Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network
Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57
2017
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
-
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment
Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268
2015
-
Factors associated with unreported tuberculosis cases in Spanish hospitals
BMC Infectious Diseases, Vol. 15, Núm. 1
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: A multicentre experience in antiretroviral therapy-naive and -experienced patients
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 9
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Riesgo de interacciones farmacológicas por la coadministración de estatinas con fármacos metabolizados por la isoenzima 3A4 del citocromo P450: Estudio epidemiológico, transversal y multicéntrico
Medicina Clinica, Vol. 143, Núm. 10, pp. 427-432
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2013
-
Efficacy and tolerability of Darunavir/Ritonavir in combination with abacavir/lamivudine: An option in selected HIV-infected patients
HIV Clinical Trials, Vol. 14, Núm. 5, pp. 254-259
2012
-
Atherogenic dyslipidemia in patients with established coronary artery disease
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 22, Núm. 2, pp. 103-108
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial
Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968
-
Definition of advanced age in HIV infection: Looking for an age cut-off
AIDS Research and Human Retroviruses, Vol. 28, Núm. 9, pp. 800-806
2011
-
Guidelines on the treatment of chronic coinfection by trypanosoma cruzi and HIV outside endemic areas
HIV Clinical Trials, Vol. 12, Núm. 6, pp. 287-298